{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:05Z","timestamp":1793409665532,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Major histocompatibility complex (MHC) class II deficiency is one of the combined immune deficiency disorders caused by defects in the MHC class II regulatory genes leading to abnormal T cells development and function. Therefore, patients mainly present with increased susceptibility to infections, diarrhea, and failure to thrive. In this report, we present one MHC class II deficient patient with a novel presentation with Hemophagocytic Lymphohistiocytosis (HLH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Immunophenotyping of lymphocyte subpopulations and HLA-DR expression was assess by flow cytometry. Gene mutational analysis was performed by whole exome and Sanger sequencing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We reported a 7-year-old girl, who was diagnosed at age of 2 years with MHC class II deficiency by genetic testing and flow cytometry. Two years later, she developed disseminated BCGitis which was treated with proper antimicrobial agents. At the age of 7 years, she presented with clinical features fulfilling 6 diagnostic criteria of HLH including evidence of hemophagocytic activity in bone marrow aspiration. Accordingly, the diagnosis of HLH was established and the patient was started on IV Dexamethasone, Anakinra and IVIG. Eventually, patient started to improve and was discharged in good condition. Few months later, the patient was readmitted with severe pneumonia and sepsis leading to death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with MHC class II deficiency might present with disseminated BCGitis especially if the patient has severe T cell lymphopenia. Additionally, this immune defect might be added to the list of inborn errors of immunity that can be complicated with HLH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10875-024-01674-0","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T03:02:12Z","timestamp":1709262132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis"],"prefix":"10.1007","volume":"44","author":[{"given":"Fayhan J.","family":"Alroqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaab A.","family":"Alhezam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah I.","family":"Almojali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tlili","family":"Barhoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Althubaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Al Balwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alrasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"7","key":"1674_CR1","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, et al. The 2022 update of IUIS Phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508\u201320. https:\/\/doi.org\/10.1007\/s10875-022-01352-z.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1674_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","volume":"134","author":"S Hanna","year":"2014","unstructured":"Hanna S, Etzioni A. MHC class I and II deficiencies. J Allergy Clin Immunol. 2014;134(2):269\u201375. https:\/\/doi.org\/10.1016\/j.jaci.2014.06.001.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1674_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10875-012-9831-8","volume":"33","author":"W Al-Herz","year":"2013","unstructured":"Al-Herz W, Alsmadi O, Melhem M, Recher M, Frugoni F, Notarangelo LD. Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile. J Clin Immunol. 2013;33(3):513\u20139. https:\/\/doi.org\/10.1007\/s10875-012-9831-8.","journal-title":"J Clin Immunol"},{"issue":"19","key":"1674_CR4","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1182\/blood-2011-05-352716","volume":"118","author":"M Ouederni","year":"2011","unstructured":"Ouederni M, Vincent QB, Frange P, et al. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011;118(19):5108\u201318. https:\/\/doi.org\/10.1182\/blood-2011-05-352716.","journal-title":"Blood"},{"issue":"8","key":"1674_CR5","doi-asserted-by":"publisher","first-page":"ofaa314","DOI":"10.1093\/ofid\/ofaa314","volume":"7","author":"YQ Cai","year":"2020","unstructured":"Cai YQ, Zhang H, Wang XZ, et al. A novel RFXANK mutation in a Chinese child with MHC II Deficiency: Case Report and Literature Review. Open Forum Infect Dis. 2020;7(8):ofaa314. https:\/\/doi.org\/10.1093\/ofid\/ofaa314. Published 2020 Jul 24.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"1674_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s1074-7613(03)00086-4","volume":"18","author":"N Nekrep","year":"2003","unstructured":"Nekrep N, Fontes JD, Geyer M, Peterlin BM. When the lymphocyte loses its clothes. Immunity. 2003;18(4):453\u20137. https:\/\/doi.org\/10.1016\/s1074-7613(03)00086-4.","journal-title":"Immunity"},{"issue":"3","key":"1674_CR7","first-page":"219","volume":"12","author":"S Alyasin","year":"2015","unstructured":"Alyasin S, Abolnezhadian F, Khoshkhui M. A case of probable MHC class II Deficiency with disseminated BCGitis. Iran J Immunol. 2015;12(3):219\u201325.","journal-title":"Iran J Immunol"},{"issue":"12","key":"1674_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1182\/blood.2019002690","volume":"135","author":"SH Lum","year":"2020","unstructured":"Lum SH, Anderson C, McNaughton P, et al. Improved transplant survival and long-term disease outcome in children with MHC class II deficiency. Blood. 2020;135(12):954\u201373. https:\/\/doi.org\/10.1182\/blood.2019002690.","journal-title":"Blood"},{"issue":"2","key":"1674_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"key":"1674_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coi.2017.08.004","volume":"49","author":"FE Sepulveda","year":"2017","unstructured":"Sepulveda FE, de Saint Basile G. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol. 2017;49:20\u20136. https:\/\/doi.org\/10.1016\/j.coi.2017.08.004.","journal-title":"Curr Opin Immunol"},{"issue":"16","key":"1674_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"SW Canna","year":"2020","unstructured":"Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135(16):1332\u201343. https:\/\/doi.org\/10.1182\/blood.2019000936.","journal-title":"Blood"},{"issue":"3","key":"1674_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/pbc.22830","volume":"56","author":"C Parekh","year":"2011","unstructured":"Parekh C, Hofstra T, Church JA, Coates TD. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease. Pediatr Blood Cancer. 2011;56(3):460\u20132. https:\/\/doi.org\/10.1002\/pbc.22830.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1674_CR13","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1097\/MPH.0000000000001803","volume":"42","author":"PG Cetinkaya","year":"2020","unstructured":"Cetinkaya PG, Cagdas D, Gumruk F, Tezcan I. Hemophagocytic Lymphohistiocytosis in patients with primary immunodeficiency. J Pediatr Hematol Oncol. 2020;42(6):e434\u20139. https:\/\/doi.org\/10.1097\/MPH.0000000000001803.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"1674_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3324\/haematol.2014.121608","volume":"100","author":"SF Bode","year":"2015","unstructured":"Bode SF, Ammann S, Al-Herz W, et al. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica. 2015;100(7):978\u201388. https:\/\/doi.org\/10.3324\/haematol.2014.121608.","journal-title":"Haematologica"},{"key":"1674_CR15","doi-asserted-by":"publisher","unstructured":"Marciano BE, Huang CY, Joshi G et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies [published correction appears in J Allergy Clin Immunol. 2014;134(1):244]. J Allergy Clin Immunol. 2014;133(4):1134\u20131141. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.028.","DOI":"10.1016\/j.jaci.2014.02.028"},{"key":"1674_CR16","doi-asserted-by":"publisher","first-page":"745483","DOI":"10.1155\/2012\/745483","volume":"2012","author":"YV Cavalcanti","year":"2012","unstructured":"Cavalcanti YV, Brelaz MC, Neves JK, Ferraz JC, Pereira VR. Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis. Pulm Med. 2012;2012:745483. https:\/\/doi.org\/10.1155\/2012\/745483.","journal-title":"Pulm Med"},{"issue":"1","key":"1674_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00043426-199302000-00012","volume":"15","author":"F Fujiwara","year":"1993","unstructured":"Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol. 1993;15(1):92\u20138. https:\/\/doi.org\/10.1097\/00043426-199302000-00012.","journal-title":"Am J Pediatr Hematol Oncol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01674-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01674-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01674-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:16:42Z","timestamp":1713871002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01674-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01674-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"16 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"73"}}